Movement Disorders in Developmental and Epileptic Encephalopathies
Movement Disorders Clinical Practice · 2026-10 · 13 (10) · 2328-2340
DOI: 10.1002/mdc3.70641 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Movement Disorders Clinical Practice, online erschienen am 01.05.2026. Verfasst von Shekeeb Mohammad und 2 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine and Health, Sydney Medical School, The University of Sydney, Sydney, NSW, Australia. Hauptthemen laut MEDLINE: Movement Disorders, Epilepsy. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 171 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
Monogenic developmental and epileptic encephalopathies (DEE) frequently feature co‐occurring movement disorders. Gene discovery has expanded epilepsy‐dyskinesia syndromes (EDS) from classic associations such as stereotypies in Rett syndrome to PRRT2‐related infantile seizures with paroxysmal dyskinesia and crouched gait in SCN1A‐associated Dravet syndrome.
Objectives
To outline the movement disorders spectrum in EDS, propose a pragmatic syndrome‐based clinical framework, group implicated genes into mechanistic categories, highlight selected genotype–phenotype correlations, and summarize symptomatic and precision therapeutic options.
Methods
A non‐systematic, structured literature review identified monogenic disorders reported with EDS, grouping publications into four tiers: multi‐etiology cohorts; small series and narrative/systematic reviews; single‐gene or pathway‐focused reports; and mechanistic/therapeutic studies.
Results
Eight cohort studies and multiple tier 2–3 series and reviews yielded 245 single‐gene associations, most mapping to ion channel and synaptic signaling pathways. Across DEE cohorts, movement disorders occurred in roughly one‐quarter to over one‐half of patients, were often hyperkinetic (notably dystonia and stereotypies), and frequently combined multiple phenomenologies. We grouped clinical presentations into early and late infantile‐onset EDS, Rett and Rett‐like syndromes, paroxysmal/episodic and relapsing–remitting disorders, disorders with severe acute motor exacerbations, and hypokinetic/progressive phenotypes. Treatments are guided by gene‐ and mechanism‐informed strategies including sodium‐channel blockers, glutamatergic modulators, ketogenic diet, agents for paroxysmal dyskinesias, and deep brain stimulation in life‐threatening crises.
Conclusions
Movement disorders are common, often severe, and genetically heterogeneous across EDS. A syndrome‐based approach integrating clinical features, neuroimaging, and broad genetic testing (including copy number variants and repeat expansions) can guide symptomatic management and emerging precision therapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Faculty of Medicine and Health, Sydney Medical School, The University of Sydney, Sydney, NSW, Australia.
- Kids Neuroscience Centre, TY Nelson Department of Neurology and Neurosurgery, The Children's Hospital at Westmead, Westmead, NSW, Australia.
- Movement Disorders Program, Department of Neurology & F.M. Kirby Neurobiology Center, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.
- Movement Disorders Unit, Neurology Department, Westmead Hospital, Westmead, NSW, Australia.
Zitieren
APA
Mohammad, S., Ebrahimi-Fakhari, D., & Morales-Briceno, H. (2026). Movement Disorders in Developmental and Epileptic Encephalopathies. Movement Disorders Clinical Practice, 13(10), 2328-2340. https://doi.org/10.1002/mdc3.70641
Vancouver
Mohammad S, Ebrahimi-Fakhari D, Morales-Briceno H. Movement Disorders in Developmental and Epileptic Encephalopathies. Movement Disorders Clinical Practice. 2026;13(10):2328-2340. doi:10.1002/mdc3.70641
BibTeX
@article{Mohammad2026,
author = {Mohammad, Shekeeb and Ebrahimi-Fakhari, Darius and Morales-Briceno, Hugo},
title = {Movement Disorders in Developmental and Epileptic Encephalopathies},
journal = {Movement Disorders Clinical Practice},
year = {2026},
volume = {13},
number = {10},
pages = {2328--2340},
doi = {10.1002/mdc3.70641}
}
EUVIMED